Clinical Trials on Vacuolar Proton-Translocating ATPases in Canada
Total 282 results
-
Ciusss de L'Est de l'Île de MontréalExCellThera inc.; Centre C3iActive, not recruitingMultiple MyelomaCanada
-
University of AlbertaCompleted
-
University of AlbertaNot yet recruitingMultiple Myeloma | Exercise | PrehabilitationCanada
-
University Health Network, TorontoMultiple Myeloma Research ConsortiumTerminatedMultiple Myeloma | Relapsed/RefractoryCanada
-
CancerCare ManitobaCompletedLymphoma | Multiple MyelomaCanada
-
Ottawa Hospital Research InstituteRecruiting
-
AHS Cancer Control AlbertaAbbott; Tom Baker Cancer CentreCompleted
-
AHS Cancer Control AlbertaTom Baker Cancer CentreRecruitingMyeloma | Myeloma MultipleCanada
-
Maisonneuve-Rosemont HospitalCompletedMultiple Myeloma | High-Risk CancerCanada
-
AEterna ZentarisCompletedMultiple Myeloma and Plasma Cell NeoplasmCanada
-
University of British ColumbiaTerminatedAnti-Xa ActivityCanada
-
Dr. Nicole Culos-ReedCompletedHematologic Neoplasms | Multiple Myeloma | Advanced CancerCanada
-
University Health Network, TorontoCompletedMultiple Myeloma | AmyloidosisCanada
-
Ciusss de L'Est de l'Île de MontréalCelgene; C3i Center Inc.Active, not recruitingMultiple Myeloma | Relapsed Hematologic MalignancyCanada
-
University Health Network, TorontoCompletedMultiple Myeloma | Renal FailureCanada
-
Genzyme, a Sanofi CompanyCompletedLymphoma, Non-Hodgkin | Multiple MyelomaCanada
-
PETHEMA FoundationBristol-Myers Squibb; Celgene; Adknoma Health Research, S.L.TerminatedMultiple MyelomaSpain
-
Emory UniversityMillennium Pharmaceuticals, Inc.; Ortho Biotech, Inc.CompletedProtocol of the Combination of Bortezomib and Tipifarnib for Relapsed or Refractory Multiple MyelomaMultiple MyelomaUnited States, Canada
-
Alberta Health Services, CalgaryAlberta Cancer Foundation; University of VictoriaRecruitingLymphoma | Leukemia | Multiple Myeloma | Blood Cancer | Stem Cell Transplant Complications | Chimeric Antigen Receptor T-cell TherapyCanada
-
London Health Sciences CentreCanadian Institutes of Health Research (CIHR); The Kidney Foundation of CanadaCompletedMultiple Myeloma | Acute Renal FailureCanada
-
Canadian Myeloma Research GroupMerck Sharp & Dohme LLCWithdrawn
-
World Federation of HemophiliaRecruitingHemophilia A | Hemophilia B | Von Willebrand DiseasesCanada
-
GlaxoSmithKlineTerminatedRelapsed/Refractory Multiple MyelomaAustralia, Sweden, Canada
-
Janssen-Ortho Inc., CanadaOrtho Biotech CanadaNo longer available
-
Lawson Health Research InstituteThe Ottawa Hospital; Hamilton Health Sciences Corporation; Dalhousie University; Niagara Health SystemActive, not recruitingMultiple Myeloma in Relapse | Multiple Myeloma With Failed Remission | Multiple Myeloma Stage I | Multiple Myeloma Progression | Multiple Myeloma Stage II | Multiple Myeloma Stage IIICanada
-
Mayo ClinicNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States, Canada
-
Washington University School of MedicineBristol-Myers Squibb; CelgeneActive, not recruitingMultiple Myeloma in RelapseUnited States, Canada
-
Canadian Cancer Trials GroupCanadian Institutes of Health Research (CIHR); Myeloma CanadaRecruiting
-
National Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaCanada
-
University Health Network, TorontoPrincess Margaret Hospital, CanadaCompletedLymphoma | Multiple Myeloma | Influenza A Virus, H1N1 SubtypeCanada
-
University of ChicagoNational Cancer Institute (NCI); Multiple Myeloma Research FoundationRecruitingMultiple MyelomaUnited States, Canada
-
NCIC Clinical Trials GroupAstex Pharmaceuticals, Inc.Completed
-
University Health Network, TorontoPrincess Margaret Hospital, Canada; Ortho Biotech, Inc.Completed
-
University Health Network, TorontoAstellas Pharma Inc; Multiple Myeloma Research ConsortiumTerminatedMultiple MyelomaUnited States, Canada
-
University of AlbertaSocial Sciences and Humanities Research Council of CanadaRecruitingMelanoma | Cancer | Breast Cancer | Multiple Myeloma | Colorectal Cancer | Ovarian Cancer | Lung Cancer | Prostate Cancer | Chronic Leukemia | Tyrosine Kinase MutationCanada
-
AHS Cancer Control AlbertaCross Cancer InstituteCompletedSarcoma | Kidney Neoplasms | Testicular Neoplasms | Multiple Myeloma | Ovarian NeoplasmsCanada
-
University of Michigan Rogel Cancer CenterCompletedMultiple MyelomaUnited States, Canada
-
Genzyme, a Sanofi CompanyCompleted
-
Thomas Martin, MDSanofi; AmgenActive, not recruitingMultiple MyelomaUnited States, Canada
-
Ontario Clinical Oncology Group (OCOG)PfizerNot yet recruitingRefractory Multiple MyelomaCanada
-
Canadian Myeloma Research GroupCompletedMultiple Myeloma in RelapseCanada
-
Canadian Myeloma Research GroupActive, not recruiting
-
Canadian Cancer Trials GroupAmgen; Canadian Myeloma Research GroupCompleted
-
Ciusss de L'Est de l'Île de MontréalUnknownRelapsed Multiple Myeloma | Relapsed Non Hodgkin Lymphoma | Hematologic Cancer | Relapsed Adult AML | Relapse Leukemia | Relapsed Adult ALL | Relapsed CLL | Relapsed Hodgkin's Lymphoma | Relapsed Myelodysplastic SyndromesCanada
-
Sunnybrook Health Sciences CentreAstraZenecaRecruitingWaldenstrom MacroglobulinemiaCanada
-
Alaunos TherapeuticsCompleted
-
PfizerBristol-Myers SquibbRecruiting
-
Jonsson Comprehensive Cancer CenterGenentech, Inc.Completed
-
University of ChicagoNational Cancer Institute (NCI)Active, not recruitingStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple MyelomaUnited States, Canada
-
Janssen-Ortho Inc., CanadaTerminated